Page last updated: 2024-10-31

metoprolol and MEA 2a

metoprolol has been researched along with MEA 2a in 2 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scholten, A1
Vriens, MR1
Cromheecke, GJ1
Borel Rinkes, IH1
Valk, GD1
Sibal, L1
Jovanovic, A1
Agarwal, SC1
Peaston, RT1
James, RA1
Lennard, TW1
Bliss, R1
Batchelor, A1
Perros, P1

Other Studies

2 other studies available for metoprolol and MEA 2a

ArticleYear
Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients.
    European journal of endocrinology, 2011, Volume: 165, Issue:1

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagon

2011
Phaeochromocytomas presenting as acute crises after beta blockade therapy.
    Clinical endocrinology, 2006, Volume: 65, Issue:2

    Topics: Acute Disease; Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic beta-Antagonists; Adult; Cardiomyo

2006